Advanced Search

 

Study ID Status Title Patient Level Data
347414/036 Completed A phase-3, open, controlled study to assess the safety and immunogenicity of four different formulations of GSK Biologicals’ investigational vaccination regimen when administered as a booster to healthy infants, 12 to 16 months old, previously vaccinated in infancy in a primary study 347414/023 Study Listed on ClinicalStudyDataRequest.com
371594/006 Completed A phase II, open, randomized study to assess the immune memory induced by a primary vaccination course of an investigational vaccination regimen and the immunogenicity and reactogenicity of a fourth dose of an investigational vaccination regimen, to healthy toddlers primed in study 371594/004. Study Listed on ClinicalStudyDataRequest.com
385/004 Completed Randomized, 2-way crossover, bioequivalence study of tranylcypromine sulfate 10mg tablets: Parnate® film-coated tablets of GlaxoSmithKline USA and Parnate® sugar-coated tablets of GlaxoSmithKline Canada administered as 1 x 10mg film-coated tablet or sugar-coated tablet…
393229/005 Completed Phase II Study Of Iodine-131 Anti-B1 Antibody Plus CHOP For Patients With Previously Untreated Mantle Cell Lymphoma
393229/007 Completed PHASE II MULTICENTER STUDY OF IODINE-131 ANTI-B1 ANTIBODY CONSOLIDATION FOR PATIENTS WITH DIFFUSE LARGE B-CELL NON-HODGKIN'S LYMPHOMA FOLLOWING FIRST-LINE CHOP Study Listed on ClinicalStudyDataRequest.com
393229/010 Completed Retreatment Study of Patients with Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody Study Listed on ClinicalStudyDataRequest.com
393229/023 Completed Fludarabine monophosphate followed by Iodine I 131 Tositumomab for untreated low-grade and follicular non-Hodgkin's lymphoma Study Listed on ClinicalStudyDataRequest.com
393229/027 Completed A Multi-Center Study to Examine the Pharmacokinetics, Whole Body and Organ Dosimetry, and Biodistribution of Fission-Derived Iodine I 131 Tositumomab for Patients With Previously Untreated or Relapsed Follicular or Transformed Follicular Non-Hodgkin's Lymphoma Study Listed on ClinicalStudyDataRequest.com
393229/028 Completed A Multi-Center, Randomized, Phase 3 Study of Rituximab versus Iodine I 131 Tositumomab Therapeutic Regimen For Patients With Relapsed Follicular Non-Hodgkins Lymphoma Study Listed on ClinicalStudyDataRequest.com
393229/028 Completed A Multi-Center, Randomized, Phase 3 Study of Rituximab versus Iodine I 131 Tositumomab Therapeutic Regimen For Patients With Relapsed Follicular Non-Hodgkins Lymphoma Study Listed on ClinicalStudyDataRequest.com
393229/032 Completed A single arm, open-label, multicentre, phase II study of Tositumomab and Iodine 131-Tositumomab in subjects with indolent non-Hodgkin's Lymphoma who have previously received Rituximab.
402764/004 Completed A phase III, open, randomized study to evaluate the immunogenicity and reactogenicity of investigational vaccination regimens Study Listed on ClinicalStudyDataRequest.com
402764-003 Completed A phase II, open, randomized study to assess the immune memory induced by a primary vaccination course of an investigational vaccination regimen and the immunogenicity and reactogenicity of a fourth dose of an investigational vaccination regimen given to healthy toddlers primed in study 402764-001
404 Completed Effect of chronic Wellbutrin SR administration on craving, withdrawal, and impairment of cognitive performance associated with nicotine abstinence.
404286/006 Completed A phase II, open, randomized, controlled study to assess the immune memory induced by an investigational vaccination regimen and the safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen in toddlers primed in study 404286/001. Study Listed on ClinicalStudyDataRequest.com
407 Completed Pharmacokinetics and metabolism of Wellbutrin (bupropion hydrochloride) sustained-release in healthy smokers versus non-smokers.
408DP-02 Completed A Multi-Centre Randomized, Double-Blind, Parallel-Group, Comparison of Salmeterol Xinafoate Inhalation Rotadisk Versus Tulobuterol Tape in Subjects with Persistent Adult Asthma Treated with Inhaled Corticosteroid.
408DP-03 Completed A Multi-Centre, Randomized, Double-Blind, Parallel-Group, Comparison of Salmeterol Xinafoate Inhalation Rotadisk Versus Placebo in Subjects with Chronic Obstructive Pulmonary Disease Treated with Current Medications.
40UK Completed Effect of multiple doses of bupropion on antipyrine disposition in healthy volunteers.
40UKA Completed The disposition of bupropion and its basic metabolites in young and elderly healthy volunteers.
424323/007 Completed A study to assess the effect of repeat dosing of a New Chemical Entity (NCE) on the steady-state pharmacokinetics and pharmacodynamics of digoxin in healthy volunteers.
430C/83/6 Completed The single dose kinetics in man of 120mg of BW430C, a potential anticonvulsant.
444563/001 Completed A phase I, double-blind, randomized, placebo-controlled study of the safety and reactogenicity of a single oral dose of the SmithKline Beecham Biologicals’ live attenuated human rotavirus (HRV) vaccine in healthy adults aged 18 to 45 years
444563/002 Completed A phase I, double-blind, randomized, placebo-controlled study of the safety and reactogenicity of GSK Biologicals’ live attenuated human rotavirus vaccine at 2 different virus concentrations in healthy seropositive children between 1 and 3 years of age, when given as a single oral administration Study Listed on ClinicalStudyDataRequest.com
444563/003 Completed A phase II, double-blind, randomized, placebo-controlled, dose-escalating, stepwise study to assess safety, reactogenicity and immunogenicity of GlaxoSmithKline Biologicals’ live attenuated human rotavirus (HRV) vaccine in healthy infants previously uninfected with human rotavirus. Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.